Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?

Page 1 of 2

Is Novo Nordisk A/S (ADR) (NYSE:NVO) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments (for some reason media paid a ton of attention to Ackman’s gigantic JC Penney and Valeant failures) and it is a fact that hedge funds’ picks don’t beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

Is Novo Nordisk A/S (ADR) (NYSE:NVO) undervalued? The best stock pickers are turning less bullish. The number of long hedge fund positions were trimmed by 1 lately. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Intel Corporation (NASDAQ:INTC), Comcast Corporation (NASDAQ:CMCSA), and International Business Machines Corp. (NYSE:IBM) to gather more data points.

Follow Novo Nordisk A S (NYSE:NVO)
Trade (NYSE:NVO) Now!

In the financial world there are a lot of signals stock traders can use to assess their holdings. Some of the most innovative signals are hedge fund and insider trading sentiment. We have shown that, historically, those who follow the top picks of the best fund managers can beat their index-focused peers by a healthy margin (see the details here).

Keeping this in mind, let’s take a glance at the recent action surrounding Novo Nordisk A/S (ADR) (NYSE:NVO).

What does the smart money think about Novo Nordisk A/S (ADR) (NYSE:NVO)?

At Q3’s end, a total of 17 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -6% from one quarter earlier. With the smart money’s sentiment swirling, there exists a select group of noteworthy hedge fund managers who were boosting their holdings meaningfully (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Renaissance Technologies holds the number one position in Novo Nordisk A/S (ADR) (NYSE:NVO). Renaissance Technologies has a $714.4 million position in the stock, comprising 1.7% of its 13F portfolio. Coming in second is Fisher Asset Management, managed by Ken Fisher, which holds a $632 million position; 1.3% of its 13F portfolio is allocated to the company. Other professional money managers with similar optimism comprise Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, Tom Gayner’s Markel Gayner Asset Management and Richard Driehaus’ Driehaus Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!